PUNE, India, September 21, 2016 /PRNewswire/ --
The Global Rheumatoid Arthritis Market Report: 2016 Edition research of 47 pages providing profiles of 4 leading companies is supported with 28 Charts as well as 8 data tables and is now available in the pharmaceuticals industry segment of MarketReportsOnline.com.
The report offers an in-depth analysis of the "Global Rheumatoid Arthritis Market" segmented into global and regional market. Competition is concentrated in the hands of few major pharmaceutical companies. Major RA companies that have been covered in the report include AbbVie, JNJ, Amgen Inc. and Pfizer Inc. Complete report is now available at http://www.marketreportsonline.com/489718.html.
Arthritis means inflammation in a joint. This inflammation causes redness, warmth, swelling, and pain within the joint. Rheumatoid Arthritis is a chronic inflammation disorder affecting joints those in the hands and feet. It is triggered by a faulty immune system causing chronic inflammation of the joints. Common arthritis joint symptoms include swelling, stiffness and decreased range of motion, but if it stays for too long, it might cause permanent joint damage.
Rheumatoid arthritis usually falls in one of the two groups Seropositive Rheumatoid Arthritis and Seronegative Rheumatoid Arthritis. Family history and Smoking is the most significant reasons for causing rheumatoid arthritis. It has been observed that smokers are at more risk, particularly men. Non-genetic reason which is believed to the cause of RA is vitamin D deficiency. It occurs in four stages and can be diagnosed through medical history, blood tests, physical exams etc.
The global rheumatoid arthritis market is expected to be driven by key factors such as increasing female population, growing health care expenditure, increasing obese population, and rising cigarette consumption. However, industry growth is hindered by increasing treatment costs and high cost associated with R&D. The global rheumatoid arthritis market is rather concentrated with few pharmaceutical companies dominating the market through new drug approval.
The research report, "Global Rheumatoid Arthritis Market: 2016 Edition" provides an extensive research and detailed analysis of the market performance at present and future outlook of the global rheumatoid arthritis market. Prevalence of rheumatoid arthritis and population on biologics and anti-TNFs drugs of the overall market has been analyzed. The rheumatoid arthritis report discusses the major trends of the market such as increasing completion from anti-IL6 drugs, rising FDA approvals, use of complementary and alternative medicines along with the conventional medicine course and increasing biosimilars drug class in the market.
Purchase a copy of this "Global Rheumatoid Arthritis Market Report: 2016 Edition" research at http://www.marketreportsonline.com/contacts/purchase.php?name=489718.
Company Coverage of Global Rheumatoid Arthritis Market: AbbVie, Johnson & Johnson, Amgen Inc. & Pfizer Inc.
Partial List of Charts Provided in Global Rheumatoid Arthritis Market 2016 Edition Report:
Global Rheumatoid Arthritis Market by Value (2015-2020E)
Global Rheumatoid Arthritis Market by Drug Class (2015/2020E)
Global Rheumatoid Arthritis Market Share by Drug (2016E)
Global Rheumatoid Arthritis Market Share by Biologics (2015)
The US Rheumatoid Arthritis Market by Value (2015-2020E)
The US Rheumatoid Arthritis Patient Prevalence (2015-2020E)
The US Rheumatoid Arthritis Patient Penetration Rate (2015-2020E)
The US Rheumatoid Arthritis Anti-TNF Population (2015-2020E)
The US Rheumatoid Arthritis Biologics Population (2015-2020E)
Global Female Population (2010-2015)
Increasing Global Ageing Population of 60 Years or Older (2000-2030E)
Rheumatoid Arthritis Drug Prices (2013-2016E)
Rheumatoid Arthritis Market Share by Company (2015/2020E)
Other Related Reports on Rheumatoid Arthritis Market:
Global Rheumatoid Arthritis Partnering 2010 to 2016: The report provides understanding and access t- the partnering deals and agreements entered int- by the world's leading healthcare companies. The rheumatoid arthritis report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right t- license the licensors technology. These deals tend t- be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Complete report with Table of Contents available at http://www.marketreportsonline.com/327650.html.
Juvenile Rheumatoid Arthritis-Pipeline Insights, 2016: report provides in depth insights on the pipeline drugs and their development activities around the Juvenile Rheumatoid Arthritis. It covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Complete report available at http://www.marketreportsonline.com/439572.html.
Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.
Market Reports Online comprises of an online library of 250,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd floor, Metropole, Next to Inox theatre,
Bund garden road, Pune-411001
Tel: +1 888 391 5441
SOURCE Market Reports Online